While in 3 of 5 primary cell samples dinaciclib treatment resulted in down-regulation of p-Rb at 6 h, in 2 of the samples the level of p-Rb remained the same (AML 02) or even increased (AML 06), followed by complete inhibition of p-Rb at 24 h. Here, RB1 is linked to acute myeloid leukemia.